SS
SRPT icon

Sunbelt Securities’s Sarepta Therapeutics SRPT Stock Holding History

Sunbelt Securities’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.38K Sell
247
-2
-0.8% -$39 ﹤0.01% 1659
2025
Q4 		$5.36K Hold
249
– – ﹤0.01% 1621
2025
Q3 		$4.8K Sell
249
-35
-12% -$624 ﹤0.01% 1647
2025
Q2 		$34.5K Sell
284
-77
-21% -$3.29K ﹤0.01% 1023
2025
Q1 		$23K Buy
361
+77
+27% +$8.11K ﹤0.01% 1089
2024
Q4 		$34.4K Hold
284
– – ﹤0.01% 1022
2024
Q3 		$35.5K Buy
284
+232
+446% +$32.1K ﹤0.01% 1028
2024
Q2 		$8.22K Hold
52
– – ﹤0.01% 1298
2024
Q1 		$6.73K Hold
52
– – ﹤0.01% 1307
2023
Q4 		$5.01K Buy
52
+2
+4% +$192 ﹤0.01% 1311
2023
Q3 		$6.06K Hold
50
– – ﹤0.01% 1269
2023
Q2 		$5.73K Hold
50
– – ﹤0.01% 1303
2023
Q1 		$6.8K Buy
+50
New +$6.49K ﹤0.01% 1223

Other funds holding SRPT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Sunbelt Securities's SRPT Position: Q1 2026 in Review

Sunbelt Securities reduced its Sarepta Therapeutics (SRPT) stake by 0.8% in Q1 2026, selling an estimated $39 and leaving 247 shares worth $5.38K. The position accounts for ﹤0.01% of the portfolio, ranked #1659.

Sunbelt Securities first reported a position in SRPT in Q1 2023 and has held it in 13 quarters since. The position peaked at $35.5K in Q3 2024. 344 funds tracked by Wall St. Rank hold SRPT as of Q1 2026.

  • Sunbelt Securities held 247 shares of Sarepta Therapeutics worth $5.38K as of Q1 2026.
  • Sunbelt Securities sold 2 Sarepta Therapeutics shares in Q1 2026, an estimated $39.
  • Sarepta Therapeutics made up ﹤0.01% of Sunbelt Securities's portfolio in Q1 2026, its #1659 holding.
  • Sunbelt Securities first reported a position in Sarepta Therapeutics in Q1 2023 and has held it in 13 quarters since.
  • Sunbelt Securities's Sarepta Therapeutics position peaked at $35.5K in Q3 2024.
  • 344 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q1 2026.

Based on Sunbelt Securities's 13F filing for Q1 2026, filed 18 May 2026.